发明名称 |
Salmeterol superfine formulation |
摘要 |
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting &bgr;2-agonist by inhalation. In particular this invention relates to a chemically stable, highly efficient salmeterol HFA solution formulation to be administered by pressurized metered dose inhalers (pMDIs) characterized by a deep lung penetration. The invention also relates to methods for the preparation of said formulation and to its use in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). |
申请公布号 |
US8088362(B2) |
申请公布日期 |
2012.01.03 |
申请号 |
US20030531867 |
申请日期 |
2003.06.18 |
申请人 |
CHURCH TANYA KATHLEEN;LEWIS DAVID ANDREW;GANDERTON DAVID;MEAKIN BRIAN JOHN;BRAMBILLA GAETANO;CHIESI FARMACEUTICI S.P.A. |
发明人 |
CHURCH TANYA KATHLEEN;LEWIS DAVID ANDREW;GANDERTON DAVID;MEAKIN BRIAN JOHN;BRAMBILLA GAETANO |
分类号 |
A61K9/12;A61K9/00;A61K31/05;A61K31/11;A61K31/135;A61K31/4704;A61K31/485;A61K45/06;A61P11/06;A61P11/08 |
主分类号 |
A61K9/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|